Cardioimmunology Zurich

SEPTEMBER 14 – 16, 2022

Charterhouse Ittingen, Warth, SWITZERLAND

Congress

The meeting will highlight cutting-edge science from immunology
and cardiology and provide insight into recent developments towards
therapeutic targeting of cardiac inflammation.

?

Information

Activation and regulation of immune cells in the heart muscle and the pericardium are now recognized as key processes in cardiac diseases. Understanding and targeting the interaction of innate and adaptive immune cells with cardiomyocytes and cardiac stromal cells bears the potential to guide the development of future therapies for cardiomyopathy and heart failure patients. Cardioimmunology Zurich 2022 will highlight cutting-edge science from the fields of immunology and cardiology and provide insight into recent developments towards therapeutic targeting of cardiac inflammation.

 

Early Bird Registration: May 1, 2022

Abstract Submission Deadline: June 13, 2022

Ludewig Burkhard

Burkhard Ludewig
Head Translational Cardioimmunology, University Heart Center Zurich
Head Medical Research Center, Cantonal Hospital St. Gallen

Frank Ruschitzka

Frank Ruschitzka
Head of the University Heart Center Zurich
Clinical Director Cardiology
University Hospital Zurich

Dorthe Schmidt

Dörthe Schmidt
Senior Physician Clinic for Cardiology
University Hospital Zurich         

Gianluigi Condorelli

Gianluigi Condorelli
Director of Cardiovascular Research Area and Head of Lab
Director Department of Cardio Vascular
Medicine Humanitas Research Hospital       

Marinos Kallikourdis

Marinos Kallikourdis
Assistant Professor of Immunology and General Pathology,
Humanitas University
Group Leader, Adaptive Immunity Laboratory,
Humanitas Clinical and Research Center     

Pilar Alcaide

Pilar Alcaide
Kenneth and JoAnn G. Wellner Professor
Director, Immunology Graduate Program
Tufts University School of Medicine